Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
Sai Priya Anand, Jérémie Prévost, Manon Nayrac, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 6, pp. 100290-100290
Open Access | Times Cited: 178
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
William R. Morgenlander, Stephanie Henson, Daniel R. Monaco, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 7
Open Access | Times Cited: 81
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
Arturo Casadevall, Liise‐anne Pirofski, Michael J. Joyner
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 77
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
Stephen A. Klassen, Jonathon W. Senefeld, Katherine A. Senese, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 64
Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review
Tianbao Li, Tao Huang, Cheng Guo, et al.
The Innovation (2021) Vol. 2, Iss. 2, pp. 100116-100116
Open Access | Times Cited: 55
Role of IgM and IgA Antibodies to the Neutralization of SARS-CoV-2
Jéromine Klingler, Svenja Weiß, Vincenza Itri, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 68
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
Norma A. Valdez‐Cruz, Enrique García‐Hernández, Clara Espitia, et al.
Microbial Cell Factories (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 48
The Fc-effector function of COVID-19 convalescent plasma contributes to SARS-CoV-2 treatment efficacy in mice
Irfan Ullah, Guillaume Beaudoin-Bussières, Kelly Symmes, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100893-100893
Open Access | Times Cited: 29
Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
Tania S. Bonny, Eshan U. Patel, Xianming Zhu, et al.
Open Forum Infectious Diseases (2020) Vol. 8, Iss. 2
Open Access | Times Cited: 45
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
Sai Priya Anand, Jérémie Prévost, Manon Nayrac, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 35
ABO blood group and SARS‐CoV‐2 antibody response in a convalescent donor population
Evan M. Bloch, Eshan U. Patel, Christi E. Marshall, et al.
Vox Sanguinis (2021) Vol. 116, Iss. 7, pp. 766-773
Open Access | Times Cited: 25
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
Henry T. Peng, Shawn G. Rhind, Andrew Beckett
JMIR Public Health and Surveillance (2021) Vol. 7, Iss. 4, pp. e25500-e25500
Open Access | Times Cited: 25
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel
Kevin W. Ng, Nikhil Faulkner, Antoni G. Wrobel, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101507-101507
Open Access | Times Cited: 18
Correction: Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
Henry T. Peng, Shawn G. Rhind, Andrew Beckett
JMIR Public Health and Surveillance (2021) Vol. 7, Iss. 6, pp. e31554-e31554
Open Access | Times Cited: 17
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
Michael Asamoah-Boaheng, Brian Grunau, Mohammad Ehsanul Karim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
William R. Morgenlander, Stephanie Henson, Daniel R. Monaco, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 14
Complement inhibition: A possible therapeutic approach in the fight against Covid‐19
Niloofar Deravi, Elahe Ahsan, Mobina Fathi, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Closed Access | Times Cited: 13
Potential therapeutic landscape of COVID-19: molecular targets, repurposed drugs, and nano- and cell-based intervention
Sarika Tomar, Priyanka Surya, R. Pandey, et al.
Elsevier eBooks (2024), pp. 139-157
Closed Access | Times Cited: 1
SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines
Hadeel T. Zedan, Maria K. Smatti, Duaa W. Al‐Sadeq, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access | Times Cited: 1
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases
Claire T. Deakin, Georgina H. Cornish, Kevin W. Ng, et al.
Med (2021) Vol. 2, Iss. 9, pp. 1093-1109.e6
Open Access | Times Cited: 12
Adaptive immune responses to SARS-CoV-2
Donald N. Forthal
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 1-8
Open Access | Times Cited: 9
Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
Puthupparampil V. Scaria, Christopher G. Rowe, Beth B. Chen, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104739-104739
Open Access | Times Cited: 5
Decay of Fc-dependent antibody functions after mild to moderate COVID-19
Wen Shi Lee, Kevin J. Selva, Samantha K. Davis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 7
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
Stephen A. Klassen, Jonathon W. Senefeld, Katherine A. Senese, et al.
SSRN Electronic Journal (2021)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top